Uncategorized
Ocular Therapeutix™ to Report Fourth Quarter and Full Year 2015 Financial Results
BEDFORD, Mass.--(BUSINESS WIRE)--Ocular Therapeutix, Inc. (NASDAQ:OCUL), a biopharmaceutical company focused on the development and commercialization of innovative therapies for diseases and conditions of the eye, today announced that it will report financial results for the fourth quarter and full year ended December 31, 2015, on Thursday, March 10, 2016. Following distribution of the earnings release via wire services, the Ocular management team will host a live conference call and webcast at
